Viral Epidemiology

Overview of Viral Epidemiology

  • This topic includes three main segments:
    • Introduction to Viral Epidemiology
    • Emergent Viral Infections
    • Chikungunya Virus as an example of emergent viral infection

Introduction to Epidemiology

  • Definition of Epidemiology:

    • Epidemiology is defined as the study of the determinants, dynamics, and distribution of diseases in a population.
    • Epidemiological studies can encompass a range of pathogens, not exclusively viruses.
    • The population studied is not confined to humans.
  • Importance of Epidemiological Studies:

    • These studies play a crucial role in fighting against pathogens.
    • Important concepts include:
    • Prevalence and seroprevalence
    • Death rates
    • Endemic, epidemic, and pandemic classifications
    • Incubation period and period of infectivity

Key Epidemiological Concepts

  • Prevalence:

    • Defined as the ratio of cases present in the population at a specific time divided by the total population.
    • Function of both incidence (new cases) and duration of the disease.
  • Seroprevalence:

    • Refers to the presence of antibodies against a pathogen in a population.
    • Represents the cumulative experience of the population with that pathogen.
  • Death Rates:

    • Expressed in two forms:
    • Cause-specific mortality rate: Number of deaths from a disease in a given year divided by total population at that time.
    • Case fatality rate: Percentage of individuals with a specific disease who die from that disease.

Classifications of Disease Spread

  • Endemic:

    • Refers to continuous chains of transmission leading to a consistent occurrence of disease in a population.
    • Example: Dengue virus is endemic in Puerto Rico and many tourist destinations in Latin America, Southeast Asia, and Pacific islands.
  • Epidemic:

    • Defined by peak incidence of disease exceeding the endemic baseline or expected rate.
    • Example: The Ebola outbreak in West Africa, leading to over 10,884 deaths from 26,277 cases as of April 2015.
  • Pandemic:

    • A worldwide epidemic.
    • Examples: The 1918 influenza pandemic and the H1N1 pandemic in 2009, now a seasonal virus in humans and pigs.

Disease Dynamics

  • Incubation Period:
    • Interval between infection and onset of symptoms.
  • Two categories of infectious disease transmission:
    • Category A: Individuals become infectious after they are symptomatic.
    • Asymptomatic individuals are not contagious (e.g., SARS, MERS).
    • Category B: Infected individuals are contagious before showing symptoms.
    • Examples include measles, chickenpox, influenza, and Ebola.
    • Note: Quarantine is more effective in Category A than Category B.

Epidemiological Data Collection

  • Sero-epidemiology:

    • Analyzes how viruses spread in a population, providing data on prevalence and geographic distribution.
    • Utilizes detection of antibodies to ascertain how long a virus has been in a population (e.g., hepatitis B and C viruses).
  • Molecular Epidemiology:

    • Employs molecular biology tools (e.g., sequencing, phylogenetic analysis) to trace virus outbreaks.

Types of Epidemiological Investigations

  • Types of Studies:
    • These investigations determine disease incidence, prevalence, cause-effect relationships, and evaluation of risk factors.
    • Focus on three key study types:
    • Cross-sectional studies
    • Case-control studies
    • Cohort studies

Cross-Sectional Studies

  • Description:

    • Provide data on the prevalence of an outcome at a specific time, offering a snapshot.
    • Often serve descriptive purposes (surveys).
  • Advantages and Disadvantages:

    • Advantages:
    • Cost-effective and quick to conduct.
    • Often assess multiple outcomes and risk factors.
    • Disadvantages:
    • Provides only a snapshot, making causal inference difficult.
  • Examples:

    • American Association for the study of the liver conducted annual surveys to assess prevalence of anti-Hepatitis C virus antibodies among teenagers.
    • A cross-sectional serologic study protocol was developed by The Consortium for the Standardization of Influenza Seroepidemiology to estimate cumulative incidence and prevalence of cross-reactive antibodies to a novel virus.

Case Control Studies

  • Description:

    • Compare individuals with an outcome of interest (cases) and those without (controls) retrospectively.
    • Evaluate exposure frequencies to determine relationships between risk factors and disease.
  • Disadvantages:

    • Not adequate for assessing diagnostic tests as cases already have the condition.
    • Difficulty finding suitable control groups.
  • Example:

    • A study by WHO assessed potential risk factors in human illness caused by Middle East Respiratory syndrome coronavirus (MERS).

Cohort Studies

  • Description:

    • Known as prospective studies; cohorts of individuals are followed to evaluate exposure characteristics and their relation to outcomes.
    • Outcomes are measured as the study progresses.
  • Examples:

    • A study in The Lancet (2003) examined clinical progression and viral load in a SARS community outbreak.
    • A study in Transplantation (2009) investigated respiratory viral infections in lung transplant recipients.

Conclusion of Segment 1

  • The first segment of Viral Epidemiology provided foundational knowledge that will inform discussions on emergent viral diseases in the next segment.